Old Web
English
Sign In
Acemap
>
Paper
>
106 Switching stable rheumatology patients from an originator biologic to a biosimilar: resource cost in the UK
106 Switching stable rheumatology patients from an originator biologic to a biosimilar: resource cost in the UK
2018
Theresa Barnes
Ernest Wong
Kashyap Thakrar
K. M. J. Douglas
Fiona Glen
Steven Young-Min
Katie Marchbank
Andy Ingram
Keywords:
Biosimilar
Physical therapy
Rheumatology
Medicine
Internal medicine
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]